13F-HR filed by Nextech Invest Ltd.
Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 14 holding rows worth $251,362,848.
- Accession
- 0001104659-23-020685
- Filer
- CIK 1911010
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 14 entries on the cover page, a total value of $251,362,848 stated on the cover page (in dollars after the unit check, H1), rows summing to $251,362,848 with VALUE read as dollars as filed, 13F file number 028-22157. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 4,189,529 | $99,794,581 | dollars as filed | |
| EQRX INC | 26886C107 | COM | 13,104,424 | $32,236,883 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 2,518,582 | $19,141,223 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,910,029 | $16,292,547 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 2,329,480 | $14,209,828 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,221,145 | $12,883,080 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,385,807 | $12,056,521 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 263,914 | $11,957,943 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 287,251 | $9,826,857 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 188,228 | $8,246,269 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 475,485 | $7,103,746 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 611,310 | $3,044,324 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 1,451,537 | $2,351,490 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 375,857 | $2,217,556 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-020685 | this filing | 2023-02-14 | acceptance time not in the bulk data set |